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Transferrins: Molecular mechanisms of iron transport and disordersIron is an essential trace metal for all living organisms with the ex-
ception of a few members of the genus Lactobacillus and some strains
of Bacillus. Despite its abundance and special chemical properties,
iron acquisition by all living organisms presents major challenges.
On the one hand, the easy inter-conversion between ferrous (Fe2+)
and ferric (Fe3+) ions makes iron an attractive transition metal for
many biological redox processes. On the other hand, reduced iron
or “free” iron in the cell has the propensity to generate highly reac-
tive oxygen species such as hydroxyl radicals which can damage cel-
lular components including lipid membranes, nucleic acids and
proteins. To maintain the balance between iron as an essential nutri-
ent and iron as a potential cytotoxin, living organisms have devel-
oped well orchestrated homeostatic mechanisms to regulate the
absorption, transport, storage and mobilization of iron both at the
cellular and systemic levels.
Recent discoveries of major protein players affecting iron homeo-
stasis such as the divalent metal transporter 1 (DMT1), the duodenal
cytochrome b (Dcytb), hephaestin (Hp), ferroportin-1 (FPN1), hemo-
juvelin (HJV) and hepcidin emphasize the complex nature of iron me-
tabolism. The biochemistry of iron, its uptake and utilization within
the cell are incompletely understood and will likely be topics of re-
search for many years to come. Given these new ﬁndings, the para-
doxical nature of iron (abundant but poorly available) and the
catastrophic consequences of iron imbalance, it is timely to dedicate
a special issue to highlight recent advances in our understanding of
the transport of iron and the mechanisms that control and regulate
cellular iron metabolism. This special volume is divided into seven
sections encompassing the history of iron homeostasis and diseases
of iron imbalance, the X-ray structure of the transferrins, the trans-
ferrin family members and transferrin receptors, the anions and
iron uptake, transport, and release mechanisms, non-transferrin
bound iron and other aspects of transferrin structure–function
relationships.
Transferrins (Tf) are single-chain glycoproteins containing on av-
erage 700 amino acids with a molecular mass of ~80 kDa. The similar-
ity between X-ray crystal structures among transferrin family
members across all species is not surprising given the 60–80% se-
quence identity. In vertebrates, the major protein involved in the de-
livery of transferrin containing iron into cells is the plasmamembrane
transferrin receptor (TfR). Two types of TfR, TfR1 and TfR2 are known
with TfR1 being the widely expressed and the best-characterized of
the two receptors. TfR1 is a homodimeric membrane glycoprotein of
molecular mass ~190,000 Da that binds two molecules of transferrin
in a pH dependent manner and allows delivery of iron into cells.
Once in the cytosol, iron is either immediately utilized or stored in
ferritin for later use. Virtually all cells, except mature red blood
cells, have this receptor on their surface, but it is particularly abun-
dant in the erythron, placenta and liver. Following the release of0304-4165 © 2012 Elsevier B.V.
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recycled back to the cell surface where it dissociates at the higher
pH value of blood (~pH 7.4). It has been estimated that transferrin
is recycled between 100 and 200 times during its lifetime. Although,
internalization of Tf-bound iron is the predominant pathway of iron
uptake by cells under normal circumstances, compelling evidence in
the literature suggest alternative mechanisms of iron uptake includ-
ing non-Tf-bound iron transporters, divalent metal transporter 1
(DMT1), calcium channels, H-chain ferritin receptors, senescent red
blood cells, and others.
Since their discovery over six decades ago, the transferrins have
attracted much scientiﬁc interest due to their ability to reversibly bind
and release a variety of metal ions. Ground-breaking structural work
in the early 80s has deﬁned much of the chemical nature of the high
afﬁnity binding sites and has provided insight into the mechanisms
of the binding and release ofmetal ions, particularly iron.Many intensive
studies have followed andwere aimed towards a deeper understanding
of these unique iron-binding proteins, the transferrin/transferrin recep-
tor mediated cellular iron uptake pathway and the strategies that ex-
ploit the Tf/TfR complex as a drug carrier system. The determination
of the structure of the transferrin receptor 1 (TfR1), the identiﬁcation
of the mutations in the HFE gene responsible for hereditary hemochro-
matosis, and the discoveries of new players affecting iron homeostasis
have provided new insights into the complex metabolic pathways for
iron.
The twenty-four papers constituting this special volume have
been written by experts in the ﬁeld of iron metabolismwho have con-
tributed seminal ﬁndings to the ﬁeld. This collection of papers brings
together, in a concise yet comprehensive manner, our current knowl-
edge of how living organisms deal successfully with the problem of
efﬁcient transport and acquisition of iron. The reviews, recent ﬁnd-
ings and new insights contained in this special volume should serve
as an important resource for researchers in the future but also as an
inspiration for young scientists interested in pursuing studies in the
ﬁeld of iron biochemistry and metabolism.
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